Gemini Therapeutics (NASDAQ:GMTX) Sets New 12-Month High at $65.60

Shares of Gemini Therapeutics, Inc. (NASDAQ:GMTX – Get Free Report) reached a new 52-week high during trading on Monday . The stock traded as high as $65.60 and last traded at $65.21, with a volume of 178593 shares. The stock had previously closed at $64.42. Gemini Therapeutics Stock Performance The company has a market cap […]

Related Keywords

Montreal ,Quebec ,Canada , ,Gemini Therapeutics Inc ,Virtu Financial ,Nasdaq ,Renaissance Technologies ,Goldman Sachs Group Inc ,Gemini Therapeutics Company Profile ,Gemini Therapeutics ,Get Free Report ,Sachs Group ,Montreal Can ,Gemini Therapeutics Daily ,Nasdaq Gmtx ,Gmtx ,Medical ,Stocks ,Technicals ,